Clinical Trial

Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease

Study acronym: SALINE
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The SALINE trial will investigate the effect of Hypertonic Saline inhalation plus best supportive care on burden of symptoms, clearance of mycobacteria and functional capacities in participants with Mycobacterium avium complex lung disease and compare the effect to treatment with best supportive care alone.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-01-13; most recent amendment 2025-06-25.
Status change: Not Yet Recruiting → Recruiting 2022-08-09
Trial Details
NCT Number NCT05192057
Lead Sponsor Radboud University Medical Center
Conditions Nontuberculous Mycobacterial Lung Disease, Mycobacterium Avium Complex
Enrollment 30 participants
Start Date 2022-05-20
Primary Completion 2026-10-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-26